SVF ENDURANCE (CAYMAN) LTD sold 3.3% of their position (538.38K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $3.22M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/9/2025ACC: 0001493152-25-017612
10% Owner
Since Oct 2019
-538.38K
Net shares
Net seller
$3.22M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
538.38K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−72.13K
Price / share
$5.60
Trade value
$404.15K
% of position
0.4%
10/7/2025
16.16M→16.09M
Common Stock
Indirect
Shares
−466.24K
Price / share
$6.05
Trade value
$2.82M
% of position
2.9%
10/8/2025
16.09M→15.62M
Total
Net shares
−538.38K
Net value
-$3.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/7/2025 | S · Sale | −72.13K | $5.60 | $404.15K | 0.4% | 16.16M | 16.09M |
| Common Stock Indirect | 10/8/2025 | S · Sale | −466.24K | $6.05 | $2.82M | 2.9% | 16.09M | 15.62M |
| Total | −538.38K | -$3.22M | ||||||
Derivative Transactions0
No derivative transactions reported